ArticleOncotarget2017

Calyxin Y sensitizes cisplatin-sensitive and resistant hepatocellular carcinoma cells to cisplatin through apoptotic and autophagic cell death via SCF βTrCP-mediated eEF2K degradation.

Chao Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.